AbbVie Q1 2026: Sales Soar, EPS Misses episode artwork

EPISODE · Apr 29, 2026 · 1 MIN

AbbVie Q1 2026: Sales Soar, EPS Misses

from The Daily News Now! Business

AbbVies Q1 2026 earnings exceeded expectations with $15 billion in sales, a 12.4% increase from last year, but missed EPS estimates by $0.02. Despite trimming full-year guidance, analysts anticipate 8.2% revenue growth and a 45.1% EPS increase next year. The stock surged 2.9% post-earnings, reflecting investor confidence in the companys growth prospects. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/a2460da07d1dd6fa

NOW PLAYING

AbbVie Q1 2026: Sales Soar, EPS Misses

0:00 1:42

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Frequently Asked Questions

How long is this episode of The Daily News Now! Business?

This episode is 1 minute long.

When was this The Daily News Now! Business episode published?

This episode was published on April 29, 2026.

What is this episode about?

AbbVies Q1 2026 earnings exceeded expectations with $15 billion in sales, a 12.4% increase from last year, but missed EPS estimates by $0.02. Despite trimming full-year guidance, analysts anticipate 8.2% revenue growth and a 45.1% EPS increase...

Can I download this The Daily News Now! Business episode?

Yes, you can download this episode by clicking the download button on the episode player, or subscribe to the podcast in your preferred podcast app for automatic downloads.
URL copied to clipboard!